Laparoscopic Sleeve Gastrectomy in Patients with Severe Obesity Restores Adaptive Responses Leading to Nonalcoholic Steatohepatitis

Identifier:  imarina:9280666

Handle: https://hdl.handle.net/20.500.11797/imarina9280666

Authors:  Cabre, Noemi; Luciano-Mateo, Fedra; Chapski, Douglas J; Baiges-Gaya, Gerard; Fernandez-Arroyo, Salvador; Hernandez-Aguilera, Anna; Castane, Helena; Rodriguez-Tomas, Elisabet; Paris, Marta; Sabench, Fatima; Del Castillo, Daniel; del Bas, Josep M; Tome, Mercedes; Bodineau, Clement; Sola-Garcia, Alejandro; Lopez-Miranda, Jose; Martin-Montalvo, Alejandro; Duran, Raul, V; Vondriska, Thomas M; Rosa-Garrido, Manuel; Camps, Jordi; Menendez, Javier A; Joven, Jorge

Abstract:
The surgically induced remission of liver disease represents a model to investigate the signalling processes that trigger the development of nonalcoholic steatohepatitis with the aim of identifying novel therapeutic targets. We recruited patients with severe obesity with or without nonalcoholic steatohepatitis and obtained liver and plasma samples before and after laparoscopic sleeve gastrectomy for immunoblotting, immunocytochemical, metabolomic, transcriptomic and epigenetic analyses. Functional studies were performed in HepG2 cells and primary hepatocytes. Surgery was associated with a decrease in the inflammatory response and revealed the role of mitogen-activated protein kinases. Nonalcoholic steatohepatitis was associated with an increased glutaminolysis-induced production of alpha-ketoglutarate and the hyperactivation of mammalian target of rapamycin complex 1. These changes were crucial for adenosine monophosphate-activated protein kinase/mammalian target of rapamycin-driven pathways that modulated hepatocyte survival by coordinating apoptosis and autophagy and affected methylation-related epigenomic remodelling enzymes. Hepatic transcriptome signatures and differentially methylated genomic regions distinguished patients with and without steatohepatitis. Our results suggest that the increased glutaminolysis-induced alpha-ketoglutarate production and the mammalian target of rapamycin complex 1 dysregulation play a crucial role in the inefficient adaptive responses leading to steatohepatitis in obesity.